โ† All Topics / ade

FDA ADE reports for Ilunocitinib

ade_ilunocitinib_adverse_events

ade en 2026-07-22

Ilunocitinib โ€” FDA Animal & Veterinary Adverse Event (ADE) Reports

Source: openFDA animalandveterinary/event.json, the FDA Center for Veterinary Medicine (CVM) adverse event report database. Data pulled 2026-07-22. Counts are report-level: one report may list multiple reactions and multiple animals, so figures are not additive and do not imply causation. Ilunocitinib is a active ingredient.

Total reports

Ilunocitinib: 1776

Reports by species (top entries)

  • Dog 1740
  • Human 4
  • Cat 1

Top reported reactions (VEDDRA terms, top entries)

  • Lack of efficacy - NOS 321
  • Lethargy (see also Central nervous system depression in Neurological) 230
  • Diarrhoea 196
  • Vomiting 169
  • Neutropenia 168
  • Decreased haematocrit 132
  • Elevated serum alkaline phosphatase (ALP) 119
  • Lymphopenia 113
  • Elevated alanine aminotransferase (ALT) 99
  • Leucopenia NOS 97

Source JSON: pdf-raw/ade/ade_active_ingredients_2026-07-22_b10.json (openFDA animalandveterinary/event.json, pulled 2026-07-22).